Keyword Connections

crohn disease / drug therapy*

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

8

1 Certolizumab pegol for induction of remission in Crohn's disease

2 Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

3 Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease

4 Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice

5 Adalimumab induces deep remission in patients with Crohn's disease

6 A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease

7 Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease

8 Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed